Calian Group Ltd. (TSE:CGY - Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as C$53.74 and last traded at C$53.74, with a volume of 10608 shares. The stock had previously closed at C$51.67.
Analysts Set New Price Targets
Several brokerages recently issued reports on CGY. Desjardins reduced their price objective on shares of Calian Group from C$62.00 to C$59.00 and set a "buy" rating on the stock in a report on Thursday, August 14th. Ventum Financial dropped their price target on shares of Calian Group from C$60.00 to C$58.00 and set a "buy" rating for the company in a research report on Thursday, August 14th. Finally, CIBC increased their price objective on shares of Calian Group from C$50.00 to C$59.00 in a research report on Monday, July 21st. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of C$60.67.
View Our Latest Stock Analysis on Calian Group
Calian Group Stock Performance
The stock's fifty day simple moving average is C$50.60 and its 200-day simple moving average is C$47.72. The company has a current ratio of 1.29, a quick ratio of 1.20 and a debt-to-equity ratio of 39.54. The company has a market capitalization of C$603.67 million, a price-to-earnings ratio of -886.83, a price-to-earnings-growth ratio of 2.50 and a beta of 0.44.
Calian Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 9th. Stockholders of record on Tuesday, September 9th were paid a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 2.1%. The ex-dividend date was Tuesday, August 26th. Calian Group's dividend payout ratio (DPR) is presently -1,866.67%.
Calian Group Company Profile
(
Get Free Report)
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calian Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.
While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.